The Weston family Boots takeover is moving closer, with the billionaire dynasty understood to be closing in on a deal that would value the pharmacy chain at around £6.7bn including debt, according to Retail Gazette. The approach comes as Boots reported its latest financial results, underlining the scale of the business any buyer would be acquiring.
What the Westons Would Be Taking On
Boots generated £7.5bn in revenue in its latest reported financial year, a rise of 3.2 per cent, while pre-tax profit jumped 25 per cent to £337m, Retail Gazette reported. Those numbers paint a picture of a business in reasonable health: revenues climbing steadily and profits growing at a considerably faster rate, suggesting improving margins across the chain’s retail and pharmacy operations.
The Weston family are no strangers to large-scale retail and pharmacy assets. Through their holding vehicle Wittington Investments, they control Canadian supermarket giant Loblaw and pharmacy business Shoppers Drug Mart, Retail Gazette noted. A successful acquisition of Boots would extend that healthcare and retail reach into the UK market in a substantial way.
Sycamore Partners and the Question of Price
The proposed valuation of around £6.7bn, including debt, sits well below the £18bn that Sycamore Partners paid for Boots, according to City AM. That gap is considerable, and it speaks to how the perceived value of large pharmacy and health-and-beauty retail businesses has shifted over the period since that transaction. Whether the Westons and Sycamore can agree terms at that level remains the central question.
Sycamore Partners is a private equity firm, and the prospect of selling at a price so far below its own acquisition cost would represent a steep markdown. Large buyout firms do sometimes accept losses when market conditions have moved against them, but a discount of this scale would be eye-catching. Neither party has commented publicly on the state of negotiations.
Wider Market Context
The Boots situation is one of several stories weighing on British business confidence at present. Gilt yields have moved above six per cent, adding to borrowing pressures across the economy, while oil has breached $102 a barrel. A diesel supply squeeze has prompted emergency talks between a UK minister and the US Energy Secretary, adding another layer of uncertainty for businesses with fuel-intensive operations.
Against that backdrop, a deal of this size in the retail sector would carry some significance for investor sentiment. Boots is a well-established name on the British high street, with a wide network of stores and a pharmacy arm that gives it a more defensive character than pure discretionary retail. For the Weston family, adding it to a portfolio that already spans Canadian grocery and pharmacy would be a clear strategic extension.
The Weston family Boots takeover also lands at a moment when UK retail M&A has been relatively subdued. Rising interest rates and the pressure on consumer spending have made buyers cautious, and deal volumes in the sector have been lower than in earlier periods. A transaction of this scale, if completed, would stand out.
The Weston family has a long history of patient, family-capital dealmaking, and their pursuit of Boots appears consistent with that approach. Wittington Investments gives them a structure suited to long-term ownership rather than a private equity-style hold-and-sell cycle, which may itself be part of the attraction for Sycamore if it is seeking an exit that avoids a lengthy public markets process.
Retail Gazette reported that the proposed deal, valued at around £6.7bn including debt, remains at the closing-in stage, and no formal agreement has been announced. The Weston family’s next move, and Sycamore Partners’ response on price, will determine whether the transaction advances to completion.
